首页> 外文期刊>Surgical Endoscopy >Superiority of preemptive analgesia with intraperitoneal instillation of bupivacaine before rather than after the creation of pneumoperitoneum for laparoscopic cholecystectomy: a randomized, double-blind, placebo-controlled study.
【24h】

Superiority of preemptive analgesia with intraperitoneal instillation of bupivacaine before rather than after the creation of pneumoperitoneum for laparoscopic cholecystectomy: a randomized, double-blind, placebo-controlled study.

机译:腹腔镜胆囊切除术在创建气腹之前而不是在腹腔内注入布比卡因前瞻性镇痛的优势:一项随机,双盲,安慰剂对照研究。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: This study aimed to evaluate the optimal timing of preemptive analgesia with bupivacaine peritoneal instillation in a prospective, randomized, double-blind, placebo-controlled trial. METHODS: In this study, 120 patients qualified for laparoscopic cholecystectomy were randomized to four groups. Group A received 2 mg/kg of bupivacaine in 200 ml of normal saline before creation of pneumoperitoneum. Group B received 2 mg/kg of bupivacaine in 200 ml of normal saline after creation of pneumoperitoneum. Group C received 200 ml of normal saline before creation of pneumoperitoneum. Group D received 200 ml of normal saline after creation of pneumoperitoneum. Local wound infiltration with bupivacaine was used before skin incisions. The primary end points of the study were postoperative pain intensity on a visual analog scale and incidence of shoulder tip pain. The secondary end points included the latency of nurse-controlled analgesia activation, the analgesia request rate, and analgesic consumption. RESULTS: Significantly lower visual analog scores were observed in group A versus groups C and B versus group D during the initial 48 and 24 h, respectively. The patients in group A versus group B reported significantly lower pain at 4 h (p < 0.001) and 8 h (p = 0.003) postoperatively, but the difference was not significant after 12, 24, and 48 h. None of the group A patients reported shoulder tip pain, whereas it was reported by 3 patients in group B, 6 patients in group C, and 7 patients in group D (p < 0.01). The latency of nurse-controlled analgesia activation was 426.8 +/-57.2 min in group A, as compared with 307 +/- 39.8 min in group B, 109.3 +/- 51 min in group C, and 109 +/- 46.5 min in group D (p < 0.001). A significantly lower analgesia request rate was observed in group A versus C, as compared with group B versus D, throughout the entire study period (p < 0.05). CONCLUSIONS: Preemptive analgesia with bupivacaine peritoneal instillation is much more effective for pain relief if used before creation of pneumoperitoneum. Although the effect of bupivacaine peritoneal instillation is also noticeable when used after creation of pneumoperitoneum, it confers significantly lower benefits.
机译:背景:本研究旨在通过一项前瞻性,随机,双盲,安慰剂对照试验评估布比卡因腹膜内滴注先发镇痛的最佳时机。方法:本研究将120例符合腹腔镜胆囊切除术资格的患者随机分为四组。在产生气腹之前,A组接受200 mg生理盐水中的2 mg / kg布比卡因。气腹后,B组在200 ml生理盐水中接受2 mg / kg布比卡因。 C组在产生气腹前接受200 ml生理盐水。 D组在产生气腹后接受200 ml生理盐水。在皮肤切口之前使用布比卡因局部伤口浸润。该研究的主要终点是视觉模拟量表上的术后疼痛强度和肩尖疼痛的发生率。次要终点包括护士控制镇痛激活的潜伏期,镇痛要求率和镇痛药消耗。结果:在最初的48小时和24小时内,A组与C组,B组与D组的视觉模拟评分均显着降低。 A组和B组的患者术后4 h(p <0.001)和8 h(p = 0.003)的疼痛明显减轻,但在12、24和48 h后差异无统计学意义。 A组患者均无肩shoulder骨痛的报道,而B组中有3例,C组中有6例,D组中有7例(p <0.01)。 A组护士控制镇痛激活的潜伏期为426.8 +/- 57.2分钟,而B组为307 +/- 39.8分钟,C组为109.3 +/- 51分钟,而C组为109 +/- 46.5分钟。 D组(p <0.001)。在整个研究期间,与B组与D组相比,A组与C组相比,镇痛要求率显着降低(p <0.05)。结论:布比卡因腹膜内滴注先发镇痛如果在产生气腹前使用镇痛效果要好得多。尽管布比卡因腹膜滴注的效果在产生气腹膜后使用时也很明显,但其带来的益处明显较低。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号